{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:56:12Z","timestamp":1770749772505,"version":"3.50.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Total joint arthroplasties are among the most common elective procedures performed in the United States, and they are associated with postoperative pain. Gabapentin enacarbil is a prodrug with an extended-release formulation that has been proposed for multimodal postoperative analgesia, but the drug\u2019s efficacy for major arthroplasties remains unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>We enrolled 60 adult patients scheduled for primary knee or hip arthroplasty expected to remain hospitalized for at least 3 days. Eligible patients were randomly assigned to placebo or gabapentin enacarbil 600\u2009mg twice daily starting the day before surgery continuing for 3 days thereafter.<\/jats:p>\n            <jats:p>The primary outcome was analyzed using a joint hypothesis framework of pain (0 to 10 verbal response scores) and cumulative opioid consumption (mg of morphine equivalent) within the first 72 hours. Secondary outcomes were nausea and vomiting, pain persisting 90 days after surgery, duration of hospitalization, and early postoperative health status using quality of recovery score (QoR-15).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Twenty-eight patient in gabapentin enacarbil group and 32 in placebo group were analyzed. Since pain scores did not differ significantly (difference of means: \u22120.2 in pain scores; 95% confidence interval: \u22121.1, 0.7), nor did opioid consumption, conditions for joint hypothesis testing were not met. Moreover, there were no significant differences between groups for secondary outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>We did not identify statistically significant or clinically meaningful differences in our primary and secondary outcomes related to perioperative use of gabapentin enacarbil in patients having primary hip or knee arthroplasties.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ajp.0000000000001024","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T09:12:53Z","timestamp":1644311573000},"page":"250-256","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Effects of Gabapentin Enacarbil on Postoperative Pain After Hip and Knee Arthroplasty"],"prefix":"10.1097","volume":"38","author":[{"given":"Sabry S.","family":"Ayad","sequence":"first","affiliation":[{"name":"Anesthesia Institute, Fairview Hospital"},{"name":"Outcomes Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalya","family":"Makarova","sequence":"additional","affiliation":[{"name":"Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azfar K.","family":"Niazi","sequence":"additional","affiliation":[{"name":"Outcomes Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilara S.","family":"Khoshknabi","sequence":"additional","affiliation":[{"name":"Outcomes Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Stang","sequence":"additional","affiliation":[{"name":"Outcomes Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Raza","sequence":"additional","affiliation":[{"name":"Outcomes Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel D.","family":"Kim","sequence":"additional","affiliation":[{"name":"Outcomes Research"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,4]]},"reference":[{"key":"R1-20250619","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2106\/JBJS.17.01617","article-title":"Projected volume of primary total joint arthroplasty in the US, 2014 to 2030","volume":"100","author":"Sloan","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"R2-20250619","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.arth.2019.06.055","article-title":"Anesthesia and analgesia practices in total joint arthroplasty: a survey of the American Association of Hip and Knee Surgeons Membership","volume":"34","author":"Hannon","year":"2019","journal-title":"J Arthroplasty"},{"key":"R3-20250619","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3928\/01477447-20190723-06","article-title":"Postdischarge opiate-prescribing habits for primary THA and TKA: a survey of American Association of Hip and Knee Surgeons Members","volume":"42","author":"Lipof","year":"2019","journal-title":"Orthopedics"},{"issue":"9S","key":"R4-20250619","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.arth.2017.05.002","article-title":"Oral multimodal analgesia for total joint arthroplasty","volume":"32","author":"Golladay","year":"2017","journal-title":"J Arthroplasty"},{"key":"R5-20250619","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bja.2018.02.066","article-title":"Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review","volume":"120","author":"Chincholkar","year":"2018","journal-title":"Br J Anaesth"},{"key":"R6-20250619","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tips.2006.12.006","article-title":"Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission","volume":"28","author":"Dooley","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"R7-20250619","first-page":"CD007938","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"6","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20250619","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2147\/JPR.S112626","article-title":"Use of preoperative gabapentin significantly reduces postoperative opioid consumption: a meta-analysis","volume":"9","author":"Arumugam","year":"2016","journal-title":"J Pain Res"},{"key":"R9-20250619","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pain.2006.06.018","article-title":"Gabapentin and postoperative pain\u2014a systematic review of randomized controlled trials","volume":"126","author":"Ho","year":"2006","journal-title":"Pain"},{"key":"R10-20250619","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/aas.12766","article-title":"Gabapentin for post-operative pain management\u2014a systematic review with meta-analyses and trial sequential analyses","volume":"60","author":"Fabritius","year":"2016","journal-title":"Acta Anaesthesiol Scand"},{"key":"R11-20250619","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1213\/01.ane.0000261517.27532.80","article-title":"Do surgical patients benefit from perioperative gabapentin\/pregabalin? A systematic review of efficacy and safety","volume":"104","author":"Tiippana","year":"2007","journal-title":"Anesth Analg"},{"key":"R12-20250619","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/ALN.0000000000003428","article-title":"Perioperative use of gabapentinoids for the management of postoperative acute pain: a systematic review and meta-analysis","volume":"133","author":"Verret","year":"2020","journal-title":"Anesthesiology"},{"key":"R13-20250619","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jps.23467","article-title":"Pharmacokinetics, efficacy, and tolerability of a once-daily gastroretentive dosage form of gabapentin for the treatment of postherpetic neuralgia","volume":"102","author":"Chen","year":"2013","journal-title":"J Pharm Sci"},{"key":"R14-20250619","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/2049463720912496","article-title":"Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice","volume":"14","author":"Chincholkar","year":"2020","journal-title":"Br J Pain"},{"key":"R15-20250619","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00228-013-1545-1","article-title":"Meta-analyses of dose-exposure relationships for gabapentin following oral administration of gabapentin and gabapentin enacarbil","volume":"69","author":"Chen","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"R16-20250619","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5414\/CP203166","article-title":"Pharmacokinetics of immediate release, extended release, and gastric retentive gabapentin formulations in healthy adults","volume":"56","author":"Swearingen","year":"2018","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R17-20250619","doi-asserted-by":"crossref","first-page":"e000435","DOI":"10.1136\/bmjopen-2011-000435","article-title":"What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients","volume":"2","author":"Beswick","year":"2012","journal-title":"BMJ Open"},{"key":"R18-20250619","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/AAP.0b013e318251b688","article-title":"A cross-sectional survey on prevalence and risk factors for persistent postsurgical pain 1 year after total hip and knee replacement","volume":"37","author":"Liu","year":"2012","journal-title":"Reg Anesth Pain Med"},{"key":"R19-20250619","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/ALN.0000000000002238","article-title":"Persistent postsurgical pain: pathophysiology and preventative pharmacologic considerations","volume":"129","author":"Richeb\u00e9","year":"2018","journal-title":"Anesthesiology"},{"key":"R20-20250619","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpainsymman.2009.06.004","article-title":"Opioid equianalgesic tables: are they all equally dangerous?","volume":"38","author":"Shaheen","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"R21-20250619","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/ALN.0b013e318289b84b","article-title":"Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15","volume":"118","author":"Stark","year":"2013","journal-title":"Anesthesiology"},{"key":"R22-20250619","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1213\/ANE.0b013e3182504435","article-title":"Joint hypothesis testing and gatekeeping procedures for studies with multiple endpoints","volume":"114","author":"Mascha","year":"2012","journal-title":"Anesth Analg"},{"key":"R23-20250619","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/AAP.0000000000000257","article-title":"Multimodal analgesic protocol and postanesthesia respiratory depression during phase I recovery after total joint arthroplasty","volume":"40","author":"Weingarten","year":"2015","journal-title":"Reg Anesth Pain Med"},{"key":"R24-20250619","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1213\/ANE.0000000000001719","article-title":"Multimodal analgesic therapy with gabapentin and its association with postoperative respiratory depression","volume":"125","author":"Cavalcante","year":"2017","journal-title":"Anesth Analg"},{"key":"R25-20250619","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/ALN.0000000000002132","article-title":"Association of multimodal pain management strategies with perioperative outcomes and resource utilization: a population-based study","volume":"128","author":"Memtsoudis","year":"2018","journal-title":"Anesthesiology"},{"key":"R26-20250619","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12891-016-1231-4","article-title":"The efficacy of preoperative administration of gabapentin\/pregabalin in improving pain after total hip arthroplasty: a meta-analysis","volume":"17","author":"Mao","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"R27-20250619","doi-asserted-by":"crossref","first-page":"e3883","DOI":"10.1097\/MD.0000000000003883","article-title":"The use of gabapentin in the management of postoperative pain after total knee arthroplasty: a PRISMA-compliant meta-analysis of randomized controlled trials","volume":"95","author":"Han","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R28-20250619","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1213\/ANE.0b013e318249d36e","article-title":"The prevention of chronic postsurgical pain using gabapentin and pregabalin: a combined systematic review and meta-analysis","volume":"115","author":"Clarke","year":"2012","journal-title":"Anesth Analg"},{"key":"R29-20250619","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/j.pain.0000000000000838","article-title":"Perioperative pregabalin administration does not prevent chronic postoperative pain: systematic review with a meta-analysis of randomized trials","volume":"158","author":"Martinez","year":"2017","journal-title":"Pain"},{"key":"R30-20250619","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3109\/17453674.2011.636682","article-title":"Why still in hospital after fast-track hip and knee arthroplasty?","volume":"82","author":"Husted","year":"2011","journal-title":"Acta Orthop"},{"key":"R32-20250619","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12630-014-0310-y","article-title":"Randomized controlled trial of gabapentin as an adjunct to perioperative analgesia in total hip arthroplasty patients","volume":"62","author":"Paul","year":"2015","journal-title":"Can J Anaesth"},{"key":"R33-20250619","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/ALN.0000000000001804","article-title":"Perioperative gabapentin does not reduce postoperative delirium in older surgical patients: a randomized clinical trial","volume":"127","author":"Leung","year":"2017","journal-title":"Anesthesiology"},{"key":"R35-20250619","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/anae.12730","article-title":"A review of the scope and measurement of postoperative quality of recovery","volume":"69","author":"Bowyer","year":"2014","journal-title":"Anaesthesia"}],"container-title":["The Clinical Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AJP.0000000000001024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:01:28Z","timestamp":1750377688000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AJP.0000000000001024"}},"subtitle":["A Placebo-controlled Randomized Trial"],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ajp.0000000000001024","relation":{},"ISSN":["1536-5409"],"issn-type":[{"value":"1536-5409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]},"assertion":[{"value":"2020-12-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}